单位：[1]Huazhong Univ Sci & Technol,Tongji Med Coll,Internal Med Tongji Hosp,Dept Endocrinol,Wuhan 430074,Peoples R China内科学系内分泌内科华中科技大学同济医学院附属同济医院[2]Huazhong Univ Sci & Technol,Inst Hypertens,Tongji Med Coll,Internal Med Tongji Hosp,Wuhan 430074,Peoples R China高血压病研究所华中科技大学同济医学院附属同济医院内科学系心血管内科
第一作者单位：[1]Huazhong Univ Sci & Technol,Tongji Med Coll,Internal Med Tongji Hosp,Dept Endocrinol,Wuhan 430074,Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Chu Xiaojing,Ding Hu,Cui Guanglin,et al.Functional consequences of a novel point mutation in the CYP21A2 gene identified in a Chinese Han patient with nonclassic 21-hydroxylase deficiency[J].CLINICAL ENDOCRINOLOGY.2014,80(6):927-928.doi:10.1111/cen.12309.
APA：
Chu, Xiaojing,Ding, Hu,Cui, Guanglin,Xu, Yujun,Wang, Dao Wen&He, Yebing.(2014).Functional consequences of a novel point mutation in the CYP21A2 gene identified in a Chinese Han patient with nonclassic 21-hydroxylase deficiency.CLINICAL ENDOCRINOLOGY,80,(6)
MLA：
Chu, Xiaojing,et al."Functional consequences of a novel point mutation in the CYP21A2 gene identified in a Chinese Han patient with nonclassic 21-hydroxylase deficiency".CLINICAL ENDOCRINOLOGY 80..6(2014):927-928
